Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants

12 Sept 2015

Abstract excerpt

OBJECTIVES: Group B Streptococcus (GBS) surface-proteins have been shown to be immunogenic and potential vaccine candidates. We aim to determine the association between maternal IgG antibodies to select GBS surface-proteins and invasive GBS disease in their infants. METHODS: Using a matched case-control study, maternal antibody levels for GBS-immunogenic bacterial adhesin, fibrinogen-binding protein A and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neonatal and Maternal Infections
Share to Preterm Birth and Chorioamnionitis
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26364978
DOI: 10.1586/14760584.2015.1085307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infantsPMID 26364978Read ↗

Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South AfricaSemantic proximity Read ↗

Potential for Maternally Administered Vaccine for Infant Group B StreptococcusSemantic proximity Read ↗

Serological thresholds of risk reduction for infant group B streptococcus diseaseSemantic proximity Read ↗

Using Dried Blood Spots for a Sero-Surveillance Study of Maternally Derived Antibody against Group B StreptococcusSemantic proximity Read ↗

Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control studySemantic proximity Read ↗

Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.Semantic proximity Read ↗

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult womenSemantic proximity Read ↗

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectivenessSemantic proximity Read ↗

Natural immunity to pneumococcal Pilus-1 RrgA and RrgB antigens, and its relationship with pneumococcal carriageSemantic proximity Read ↗

Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.Semantic proximity Read ↗

Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants.Semantic proximity Read ↗

Intrapartum tests for group B streptococcus: accuracy and acceptability of screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.